A new study reveals that the use of psychedelic-assisted therapy for treating depression and anxiety is showing promising early results in clinical trials. Researchers highlight significant reductions in symptoms among participants after just a single session, suggesting potential breakthroughs in mental health treatment. The findings come as interest in psychedelics for therapeutic purposes grows, though experts emphasize the need for further rigorous testing. The research also underscores the importance of proper dosing and professional guidance in these experimental approaches.
